Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Racism | 4 | 2025 | 88 | 1.790 |
Why?
|
| Cognitive Dysfunction | 5 | 2020 | 344 | 1.360 |
Why?
|
| Health Behavior | 3 | 2025 | 474 | 1.210 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 848 | 1.110 |
Why?
|
| Atherosclerosis | 2 | 2025 | 156 | 1.000 |
Why?
|
| Allostasis | 3 | 2021 | 10 | 0.920 |
Why?
|
| Aging | 7 | 2024 | 754 | 0.910 |
Why?
|
| Stress, Psychological | 3 | 2021 | 479 | 0.860 |
Why?
|
| Coronary Vessels | 2 | 2022 | 124 | 0.800 |
Why?
|
| Cognition | 3 | 2025 | 491 | 0.750 |
Why?
|
| Depression | 2 | 2022 | 909 | 0.750 |
Why?
|
| Dementia | 4 | 2023 | 263 | 0.720 |
Why?
|
| Minority Groups | 2 | 2019 | 141 | 0.690 |
Why?
|
| Blood Pressure | 1 | 2019 | 517 | 0.490 |
Why?
|
| Diet | 1 | 2019 | 533 | 0.450 |
Why?
|
| United States | 11 | 2025 | 7923 | 0.420 |
Why?
|
| Social Segregation | 2 | 2026 | 11 | 0.400 |
Why?
|
| Humans | 34 | 2026 | 64252 | 0.390 |
Why?
|
| Leishmania infantum | 2 | 2023 | 8 | 0.390 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2023 | 14 | 0.390 |
Why?
|
| Risk Factors | 8 | 2025 | 5339 | 0.380 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 141 | 0.370 |
Why?
|
| Coinfection | 2 | 2023 | 58 | 0.370 |
Why?
|
| Anxiety | 1 | 2015 | 430 | 0.360 |
Why?
|
| Male | 21 | 2026 | 30305 | 0.350 |
Why?
|
| Exercise | 1 | 2019 | 954 | 0.350 |
Why?
|
| Female | 22 | 2026 | 33360 | 0.340 |
Why?
|
| DNA Methylation | 2 | 2024 | 294 | 0.340 |
Why?
|
| Aged, 80 and over | 8 | 2026 | 5527 | 0.340 |
Why?
|
| Biomarkers | 3 | 2024 | 1431 | 0.320 |
Why?
|
| Feeding and Eating Disorders | 2 | 2022 | 50 | 0.320 |
Why?
|
| Middle Aged | 10 | 2025 | 17906 | 0.310 |
Why?
|
| Aged | 14 | 2026 | 14657 | 0.310 |
Why?
|
| Young Adult | 5 | 2025 | 4780 | 0.260 |
Why?
|
| Narration | 1 | 2025 | 51 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2024 | 2604 | 0.220 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 38 | 0.210 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 43 | 0.200 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 391 | 0.200 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2023 | 16 | 0.200 |
Why?
|
| Parasites | 1 | 2022 | 16 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2024 | 144 | 0.190 |
Why?
|
| Alzheimer Disease | 3 | 2014 | 749 | 0.180 |
Why?
|
| Bulimia | 1 | 2022 | 17 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 788 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2025 | 320 | 0.170 |
Why?
|
| Health Promotion | 1 | 2025 | 505 | 0.170 |
Why?
|
| Life Style | 2 | 2022 | 317 | 0.170 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 397 | 0.170 |
Why?
|
| Nursing Homes | 3 | 2020 | 672 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2024 | 728 | 0.160 |
Why?
|
| Cancer Pain | 1 | 2020 | 16 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2019 | 33 | 0.160 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 78 | 0.150 |
Why?
|
| Disease Progression | 4 | 2015 | 1176 | 0.140 |
Why?
|
| Pain Management | 1 | 2020 | 169 | 0.140 |
Why?
|
| Pain | 1 | 2020 | 407 | 0.130 |
Why?
|
| Brain | 1 | 2026 | 1581 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 423 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 390 | 0.130 |
Why?
|
| Students | 1 | 2019 | 222 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2015 | 735 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 316 | 0.120 |
Why?
|
| Quality of Health Care | 1 | 2020 | 526 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 374 | 0.120 |
Why?
|
| Maryland | 1 | 2015 | 36 | 0.110 |
Why?
|
| HIV Infections | 1 | 2022 | 976 | 0.110 |
Why?
|
| Irritable Mood | 1 | 2015 | 16 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 19 | 0.110 |
Why?
|
| Apathy | 1 | 2015 | 9 | 0.110 |
Why?
|
| Hypertension | 1 | 2020 | 593 | 0.110 |
Why?
|
| Binge-Eating Disorder | 1 | 2014 | 13 | 0.110 |
Why?
|
| Smoking | 1 | 2019 | 861 | 0.100 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 1272 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 160 | 0.100 |
Why?
|
| Brazil | 2 | 2023 | 100 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1257 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2480 | 0.100 |
Why?
|
| Adult | 6 | 2025 | 17121 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 172 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 854 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 482 | 0.080 |
Why?
|
| Health Status | 1 | 2012 | 447 | 0.080 |
Why?
|
| Neoplasms | 1 | 2020 | 1392 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 2621 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 2047 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 794 | 0.070 |
Why?
|
| Child | 3 | 2023 | 4583 | 0.060 |
Why?
|
| California | 1 | 2026 | 175 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2026 | 221 | 0.050 |
Why?
|
| Saliva | 1 | 2024 | 100 | 0.050 |
Why?
|
| Crithidia | 1 | 2023 | 2 | 0.050 |
Why?
|
| Focus Groups | 1 | 2024 | 310 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 226 | 0.050 |
Why?
|
| Creatinine | 1 | 2022 | 133 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 329 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2022 | 85 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 123 | 0.050 |
Why?
|
| Sexism | 1 | 2022 | 33 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2022 | 3316 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 361 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 668 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 388 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 144 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 771 | 0.040 |
Why?
|
| Multimorbidity | 1 | 2020 | 50 | 0.040 |
Why?
|
| Memory | 1 | 2020 | 123 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 258 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 251 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 116 | 0.040 |
Why?
|
| Massachusetts | 1 | 2024 | 2095 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 2370 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 1669 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2026 | 2218 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 6304 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1569 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1407 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 65 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 379 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 288 | 0.030 |
Why?
|
| Naproxen | 1 | 2013 | 6 | 0.030 |
Why?
|
| Celecoxib | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2013 | 36 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 148 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 379 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2013 | 87 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2013 | 131 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 309 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1103 | 0.020 |
Why?
|
| Mental Health | 1 | 2014 | 372 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1270 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 20961 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2014 | 6732 | 0.010 |
Why?
|